Want to see DE:HNR1 full AI Analyst Report?
HNR1 Stock Chart & Stats
€253.80
€4.00(1.58%)
At close: 4:00 PM EDT
€253.80
€4.00(1.58%)
Day’s Range― - ―
52-Week Range€223.40 - €282.80
Previous CloseN/A
Volume122.76K
Average Volume (3M)135.05K
Market Cap
€33.47B
Enterprise Value€34.40B
Total Cash (Recent Filing)€1.06B
Total Debt (Recent Filing)€4.13B
Price to Earnings (P/E)3.7
Beta0.51
Next Earnings
Nov 09, 2026EPS Estimate
5.34Next Dividend Ex-DateN/A
Dividend Yield4.5%
Share Statistics
EPS (TTM)75.69
Shares Outstanding120,597,140
10 Day Avg. Volume126,419
30 Day Avg. Volume135,051
Financial Highlights & Ratios
PEG Ratio0.91
Price to Book (P/B)2.48
Price to Sales (P/S)1.20
P/FCF Ratio5.65
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€293.83Price Target Upside15.77% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering7
EPS Forecast (FY)23.02
Revenue Forecast (FY)€26.79B
Bulls Say, Bears Say
Bulls Say
Diversified Reinsurance PlatformHannover Re operates across property and casualty plus life and health reinsurance, with exposure spanning many lines and geographies. This diversification broadens its addressable market, supports long-term client relationships, and reduces reliance on any single risk category or business stream.
Strong Cash GenerationLarge operating and free cash flow indicates that Hannover Re is converting its insurance activities and investment operations into substantial liquidity. This supports claims funding, capital resilience, reinvestment, and shareholder distributions while providing flexibility through changing underwriting conditions.
Improving Capital PositionReasonable leverage and growth in equity strengthen Hannover Re’s capital base, an important competitive foundation in reinsurance. A sounder balance sheet can support underwriting capacity, absorb adverse claims experience, and preserve strategic flexibility without excessive dependence on additional borrowing.
Bears Say
Thin Operating ProfitabilityVery thin operating margins leave limited room for unfavorable claims development, expense pressure, or weaker pricing conditions before profitability is affected. Historical swings in revenue and margins also reduce confidence that recent earnings performance can be sustained consistently.
Declining Free Cash Flow GrowthAlthough absolute cash generation remains substantial, the decline in free cash flow growth signals weaker conversion than in the preceding period. Continued deterioration could constrain capital returns, reduce funding available for growth, and make earnings quality more dependent on volatile underwriting or investment outcomes.
Earnings Normalization RiskAn unusually high return on equity may reflect a temporary earnings peak rather than a stable operating level, particularly alongside the company’s volatile historical profitability. If results normalize, future returns and shareholder capital generation could be materially lower than the latest TTM suggests.
Hannover Rueck News
HNR1 FAQ
What was Hannover Rueck’s price range in the past 12 months?
Hannover Rueck lowest stock price was €223.40 and its highest was €282.80 in the past 12 months.
What is Hannover Rueck’s market cap?
Hannover Rueck’s market cap is €33.47B.
When is Hannover Rueck’s upcoming earnings report date?
Hannover Rueck’s upcoming earnings report date is Nov 09, 2026 which is in 17 days.
How were Hannover Rueck’s earnings last quarter?
Hannover Rueck released its earnings results on Aug 12, 2026. The company reported €5.77 earnings per share for the quarter, beating the consensus estimate of €5.582 by €0.188.
Is Hannover Rueck overvalued?
According to Wall Street analysts Hannover Rueck’s price is currently Undervalued.
Does Hannover Rueck pay dividends?
Hannover Rueck pays a Notavailable dividend of €12.5 which represents an annual dividend yield of 4.5%. See more information on Hannover Rueck dividends here
What is Hannover Rueck’s EPS estimate?
Hannover Rueck’s EPS estimate is 5.34.
How many shares outstanding does Hannover Rueck have?
Hannover Rueck has 120,597,140 shares outstanding.
What happened to Hannover Rueck’s price movement after its last earnings report?
Hannover Rueck reported an EPS of €5.77 in its last earnings report, beating expectations of €5.582. Following the earnings report the stock price went down -0.16%.
Which hedge fund is a major shareholder of Hannover Rueck?
Currently, no hedge funds are holding shares in DE:HNR1
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Hannover Rueck Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
€293.83 (15.77% Upside)
€293.83 (15.77% Upside)
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
14.02%
12-Months-Change
Fundamentals
Return on Equity
69.73%
Trailing 12-Months
Asset Growth
7.26%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Hannover Rueck
Hannover Rück SE, along with its group entities, offers a broad spectrum of reinsurance products and services worldwide. Operations are structured around two principal segments: Property & Casualty Reinsurance, and Life & Health Reinsurance. Within Property & Casualty Reinsurance, its offerings span traditional property and casualty coverage, facultative arrangements, extensive catastrophe excess-of-loss protection, custom-tailored structured reinsurance, and innovative insurance-linked securities. The company further specializes in risk solutions for agriculture, livestock, bloodstock, aviation, space, marine, and offshore energy industries, in addition to providing coverage for credit, surety, and political risks. Its Life & Health Reinsurance segment encompasses a range of products including group and individual credit life, enhanced annuities, collective life and health schemes, and Takaful reinsurance. It also engineers risk solutions addressing critical illness, disability, general health, longevity, long-term care, mortality, and morbidity. Beyond its core reinsurance activities, the firm delivers diverse financial solutions, such as financing new business ventures, monetizing embedded value, providing reserve and solvency relief, and assisting with the divestiture of non-core operations. Founded in 1966, the company maintains its headquarters in Hanover, Germany. It was formerly known as Hannover Rückversicherung AG before rebranding to Hannover Rück SE in March 2013. Hannover Rück SE functions as a subsidiary of Talanx AG.
HNR1 Stock 12 Month Forecast
Average Price Target
€293.83
▲(15.77% Upside)









